Investor Stock List
Ranked #773 of 8,699 institutional investors

Deep Track Capital, LP

Greenwich, CT

$5.41B
US stock portfolio at live prices · today +$54.1M (+1.01%)
Market closed. Prices as of Nov 20, 7:41 AM ET
Value at quarter end (Q3 2026)
$5.94B
Change from Q2 2026
−$845.6M (−12.46%)
Positions
64 · 13 new, 11 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $196M of stock. $286M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
GH 7.55%BMRN 7.24%IMVT 5.51%TARS 5.47%MANE 4.37%
StockSharesValue, live% of portfoliovs Q2 2026
GH Guardant Health, Inc.2,805,677$408M7.55%Reduced −17%
BMRN BioMarin Pharmaceutical Inc.6,374,395$392M7.24%Added +93%
IMVT Immunovant, Inc.9,160,801$298M5.51%Reduced −2%
TARS Tarsus Pharmaceuticals, Inc.3,806,768$296M5.47%Added +4%
MANE Veradermics Inc1,900,000$236M4.37%Reduced −5%
GMAB Genmab A/S4,182,689$215M3.97%Reduced −26%
PCVX Vaxcyte, Inc.3,513,069$205M3.79%Reduced −18%
INSM Insmed Incorporated1,350,000$195M3.61%New
VERA Vera Therapeutics, Inc.7,000,000$187M3.46%Added +75%
UTHR United Therapeutics Corporation300,040$168M3.10%Added +143%
COAG Hemab Therapeutics Holdings, Inc.3,587,796$143M2.64%Reduced −0%
LBRX LB Pharmaceuticals Inc3,352,804$134M2.48%Unchanged
MAZE Maze Therapeutics, Inc.4,083,969$132M2.45%Added +9%
OCUL Ocular Therapeutix, Inc.21,939,625$129M2.38%Added +11%
GRAL GRAIL, Inc.1,104,200$116M2.14%Reduced −40%
AXSM Axsome Therapeutics, Inc.800,000$109M2.01%Added +14%
CMPS COMPASS Pathways plc12,161,496$105M1.94%Unchanged
ORKA Oruka Therapeutics, Inc.1,069,774$104M1.93%Reduced −44%
TNGX Tango Therapeutics, Inc.4,500,000$102M1.89%Added +7%
MLTX MoonLake Immunotherapeutics8,105,290$89.4M1.65%Added +16%
GPCR Structure Therapeutics Inc.5,000,000$85.6M1.58%Added +5%
NRIX Nurix Therapeutics, Inc.6,000,000$81.6M1.51%Reduced −22%
COGT Cogent Biosciences, Inc.2,500,000$69.3M1.28%Added +25%
BBIO BridgeBio Pharma, Inc.885,882$69.3M1.28%New
CLDX Celldex Therapeutics, Inc.2,125,532$59.4M1.10%Reduced −28%
WGS GeneDx Holdings Corp.1,200,000$59.1M1.09%Added +71%
LTGO Latigo Biotherapeutics, Inc.4,408,322$58.4M1.08%New
VRDN Viridian Therapeutics, Inc.1,711,030$53.8M0.99%Reduced −52%
ATTO Attovia Therapeutics, Inc.3,207,138$50.0M0.92%New
EWTX Edgewise Therapeutics, Inc.1,148,817$47.3M0.87%New
BLLN BillionToOne, Inc.500,000$45.1M0.83%New
VSTM Verastem, Inc.5,740,850$39.4M0.73%Unchanged
BCAX Bicara Therapeutics Inc.4,100,000$37.4M0.69%Unchanged
ANIP ANI Pharmaceuticals, Inc.500,000$34.6M0.64%New
HROW Harrow, Inc.1,069,000$34.3M0.64%Added +10%
MBX MBX Biosciences, Inc.640,000$34.2M0.63%Reduced −63%
ACRS Aclaris Therapeutics, Inc.9,345,000$32.7M0.60%Unchanged
ALMS Alumis Inc.7,469,746$32.3M0.60%Added +18%
CRMD CorMedix Inc.6,274,076$31.9M0.59%Unchanged
NBIX Neurocrine Biosciences, Inc.200,000$31.3M0.58%New
DFTX Definium Therapeutics, Inc.1,000,000$29.5M0.55%Reduced −64%
ALT Altimmune, Inc.19,250,000$27.1M0.50%Unchanged
GENB Generate Biomedicines, Inc.2,507,449$26.0M0.48%Added +88%
OBX Obsidian Therapeutics, Inc.2,120,050$25.8M0.48%New
CRVS Corvus Pharmaceuticals, Inc.2,491,939$24.9M0.46%Unchanged
AVTX Avalo Therapeutics, Inc.3,610,000$24.4M0.45%Unchanged
SLDB Solid Biosciences Inc.3,565,062$23.0M0.42%Unchanged
BEAM Beam Therapeutics Inc.1,000,000$20.9M0.39%Unchanged
MNKD MannKind Corporation5,030,522$19.9M0.37%Reduced −16%
XENE Xenon Pharmaceuticals Inc.500,000$18.8M0.35%New
XNCR Xencor, Inc.540,000$18.4M0.34%Reduced −9%
STTK Shattuck Labs, Inc.3,706,734$16.9M0.31%Unchanged
OLMA Olema Oncology, Inc.2,109,951$15.1M0.28%Added +41%
XFOR X4 Pharmaceuticals, Inc.4,501,684$13.3M0.25%Reduced −23%
IPSC Century Therapeutics, Inc.9,462,645$12.5M0.23%Unchanged
DSGN Design Therapeutics, Inc.1,323,986$12.3M0.23%New
NKTR Nektar Therapeutics300,000$9.8M0.18%Unchanged
MPLT MapLight Therapeutics, Inc.1,318,101$8.5M0.16%New
ENTA Enanta Pharmaceuticals, Inc.1,000,000$8.0M0.15%Reduced −31%
KARD Kardigan, Inc.600,000$7.5M0.14%Unchanged
RXST RxSight, Inc.1,230,566$5.7M0.10%New
PMN ProMIS Neurosciences, Inc.740,117$2.4M<0.1%Reduced −11%
CNTX Context Therapeutics Inc.7,419,355$1.3M<0.1%Unchanged
ALGS Aligos Therapeutics, Inc.444,110$555K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ALNY Alnylam Pharmaceuticals, Inc.825,000$122M
IONS Ionis Pharmaceuticals, Inc.2,200,000$59.9M
PSNL Personalis, Inc.4,000,000$58.9M
CYTK Cytokinetics, Incorporated700,000$36.0M
DYN Dyne Therapeutics, Inc.1,500,000$24.0M
IMMX Immix Biopharma, Inc.2,775,000$19.5M
KURA Kura Oncology, Inc.1,978,565$14.5M
ELVN Enliven Therapeutics, Inc.225,000$10.4M
IMCR Immunocore Holdings plc311,218$8.3M
KLRA Kailera Therapeutics, Inc.700,000$8.1M
IVA Inventiva S.A.800,000$2.8M